Effect of ozone therapy on foetoplacental blood flow in hypertensive pregnant women

International Journal of Ozone Therapy

Volumn 8, Issue 2, 2009, Pages 211-216

  Tanbouli, T ^a   Mawsouf, M N ^b   Re, Lamberto ^c   Martinez Sanchez G ^d   Saaed, G ^e   El Badry, S M ^e   Nashed, A B ^e  

^a Cairo Liver Center   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF HAVANA   (Cuba)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

Foetoplacental blood flow; Hypertensive pregnant; Ozone

Indexed keywords

METHYLDOPA; OZONE;

ADULT; AERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FETUS CIRCULATION; GESTATIONAL AGE; HUMAN; MATERNAL HYPERTENSION; MULTIPARA; OZONE THERAPY; PLACENTA CIRCULATION; PREGNANCY; PRIMIGRAVIDA; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; UMBILICAL CORD BLOOD FLOW;

EID: 72449165921     PISSN: 19723539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Moore L, Persaud T: The Placenta and Foetal Membranes, WB. Saunders Company, Philadelphia, 2003.
2. Guyton A, Hall J: Pregnancy and Lactation, 10 ed., W.B. Saunders Company, Philadelphia, 2000.
3. Marik PE: Hypertensive disorders of pregnancy. Postgrad Med 121: 69-76, 2009.
4. Ross MG, Beall MH: Adult sequelae of intrauterine growth restriction. Semin Perinatol 32: 213-218, 2008. (Pubitemid 351636319)
5. Roberts JM, Pearson GD, Cutler JAet Al: Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertens Pregnancy 22, 109-127, 2003. (Pubitemid 37521363)
6. Witlin AG, Saade GR, Mattar F et Al Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 182: 607-611, 2000. (Pubitemid 30207320)
7. Moldenhauer J,Sibai B: Hypertensive Disorders of Pre-gnancy, 9 ed., Lippincott Williams & Wilkins, Philadelphia, 2003.
8. Liu X, Li L, Zhou Y, Guo J et Al: Expression and role of placental vascular endothelial growth factor in patients with pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 37: 22-24, 2002.
9. Verrazzo G, Coppola L, Luongo C et Al: Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease. Undersea Hyperb Med 22: 17-22, 1995.
10. Andikyan VM, Voloshchuk IN, Kovganko PA et Al: Morphofunctional changes in the placenta after ozone therapy. Bull Exp Biol Med 130: 715-718, 2000.
11. Belyaev A, Novikov E, Taratinov I et Al: Ozone Science and Engineering Proceedings of the 15th World Ozone Congress. Microcirculation in ozonetherapy of diabetic foot, London, 2001: 175-182.
12. Barakat S, Seif-El Nasr A, Abdel-Maksoud N et Al: The possible role of medical ozone in Angiogenesis European Ozone Seminar, Munich, 2003: 1-2.
13. th World Ozone Congress, Strasbourg, 2005: 1-9.
14. Biedunkiewicz B, Tylicki L, Nieweglowski T et Al: Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study. Int J Artif Organs 27: 29-34, 2004. (Pubitemid 38268261)
15. th World Ozone Congress, Strasbourg, 2005: 1-8.
16. th WMA General Assembly, Helsinki, Finland, June 1964.
17. Brian T: Doppler Assessment of Placental Blood Flow During Pregnancy. W. B. Saunder Company, London, 1999.
18. Baskett TF: Epidemiology of obstetric critical care. Best Pract Res Clin Obstet Gynaecol 22: 763-774, 2008.
19. Duley L: Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 67: 161-176, 2003.
20. Fisher SJ: The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2: 53, 2004.
21. Gabbe G, Bernstein IA: Intrauterine Growth Restriction, 3rd ed., Mikki Senkarik, New York, 1996.
22. LaMarca BD, Alexander BT, Gilbert JS et Al: Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med 5: Suppl A, S133-8, 2008.
23. Luft FC: Pieces of the preeclampsia puzzle. Nephrol Dial Transplant 18: 2209-2210, 2003.
24. Clavo B, Catala L, Perez JL et Al: Ozone therapy on cerebral blood flow: a preliminary report. Evid Based Complement Alternat Med 1: 315-319, 2004.
25. Bocci V, Valacchi GR, Giustarini DE et Al: Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 10: 110-116, 1999.
26. th International Annual Meeting of the Society for the Study of Pathophysiology of Preganacy, Organization Gestosis Zegreb, Croatia, 2005: 120-125.
27. Clemente-Apumayta JM, Zuev VM, Ljashko ES et Al: ozone therapy in chronic placental insufficiency. 3rd International Symposia on Ozone Applications, La Habana, Cuba, 2000: 91.
28. Makarov OV, Popoval LV: Ozone therapy in combined prevention and treatment of placental insufficiency. Akušerstvo i ginekologiâ 2002: 48-52.
29. Re L, Mawsouf MN, Menendez S et Al: Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 39: 17-26, 2008. (Pubitemid 350192013)
30. Bocci V, Borrelli E, Travagli V et Al: The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev 29: 646-682, 2009.
31. Leon Fernandez OS, Ajamieh HH, Berlanga J et Al: Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion. Transpl Int 21: 39-48, 2008. (Pubitemid 350198290)
32. Sampson S, Gerhardt M, Mandelbaum B: Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1: 165-174, 2008.